CLINICAL_TRIALS
trial_result
· 2014-09-30
Clinical Trial Update: Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients [Phase 2, Phase 3]
Summary
Update on a phase 2/3 trial evaluating nitazoxanide in chronic Hepatitis C patients; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Liver Institute, Egypt | Conditions: Hepatitis C | Phase 2, Phase 3 | Status: COMPLETED